NOTE
🌱 created from: cancer pharmacology
cancer_protocols
- ABVD
- AC_Paclitaxel
- AC_Docetaxel
- A-CMF
- AP_Doxorubicin_Cisplaitn
- ATC
- Bendamustine (CT)
- Bevacizumab_FOLFIRI
- Bevacizumab_mFOLFOX6
- CAF
- Cetuximab_FOLFIRI
- Cetuximab_FOLFOX4
- CHOP
- CMF
- COP
- DC-breast cancer
- DC-lung cancer
- Docetaxel q3w
- Docetaxel Weekly
- DTIC (Dacarbazine)
- ELF
- EP
- Fluorouracil_Leucovorin (monthly)
- Fluorouracil_Leucovorin (weekly)
- FOLFIRI
- FOLFOX4
- GC-bladder cancer (化療)
- GC-ovarian cancer
- GP (Gemcitabine_Paclitaxel)
- Trastuzumab
- HD (Trastuzumab_Docetaxel)
- HDFL (2000/300 mg)
- mFOLFOX6
- MVAC
- Nab-paclitaxel-gemcitabine
- PCb (Paclitaxel_Carboplatin)
- Pemetrexed
- PeC (Pemetrexed+Cisplatin)
- PF (3 days)
- PC (Paclitaxel_Cisplatin)
- Rituximab
- XELOX (CapeOX) q14days
- XELOX (CapeOX) q21days